These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6810198)

  • 1. Differential effects of ascorbate and EDTA on high-affinity binding of 3H-apomorphine and 3H-ADTN to calf caudate membranes.
    Arana GW; Baldessarini RJ; Kula NS
    Neuropharmacology; 1982 Jun; 21(6):601-4. PubMed ID: 6810198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the stability of 3H-dopamine, 3H-apomorphine and 3H-ADTN: effects of sodium ascorbate and EDTA.
    Cabbat FS; Manzino L; Heikkila RE
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):333-43. PubMed ID: 3922020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
    List SJ; Wreggett KA; Seeman P
    J Neurosci; 1982 Jul; 2(7):895-906. PubMed ID: 6124583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cations on high-affinity binding of 3H-ADTN to dopaminergic sites in calf caudate tissue.
    Lamont JS; Kula NS; Baldessarini RJ
    Neuropharmacology; 1987 Jun; 26(6):637-9. PubMed ID: 3601010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.
    List SJ; Seeman P
    J Neurochem; 1982 Nov; 39(5):1363-73. PubMed ID: 7119802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
    Arana GW; Baldessarini RJ; Lamont JS; Amlicke D; Neumeyer JL
    Biochem Pharmacol; 1983 Oct; 32(19):2873-80. PubMed ID: 6626260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanine nucleotides do not inhibit tritiated dopamine agonist binding to bovine striatal membranes.
    Near JA; Mahler HR
    Neurochem Res; 1982 Jul; 7(7):831-7. PubMed ID: 7121724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of [3H]apomorphine to an aporphine binding site as well as to dopamine sites in tissue from bovine caudate nucleus.
    Arana GW; Lamont JS; Baldessarini RJ; Teicher MH; Neumeyer JL; Cohen BM
    Neuropharmacology; 1984 Aug; 23(8):885-92. PubMed ID: 6483116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
    Clement-Cormier Y; Abel M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2- but not D3-dopamine receptors detected in the anterior pituitary.
    Titeler M; Van Loon GR; Seeman P; Brown GM
    Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
    Bradbury AJ; Costall B; Naylor RJ
    J Pharm Pharmacol; 1983 Nov; 35(11):738-45. PubMed ID: 6139456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor mediated inhibition by pergolide of electrically-evoked 3H-dopamine release from striatal slices of cat and rat: slight effect of ascorbate.
    Lehmann J; Arbilla S; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):31-5. PubMed ID: 7279007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptors.
    Chan B; Seeman P; Davis A; Madras BK
    Eur J Pharmacol; 1982 Jun; 81(1):111-6. PubMed ID: 6126367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.
    Osborne NN
    Cell Mol Neurobiol; 1981 Jun; 1(2):167-74. PubMed ID: 7346167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.